SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019946
Filing Date
2021-08-16
Accepted
2021-08-16 09:01:36
Documents
58
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 653661
2 ex3-2.htm EX-3.2 1770
3 ex10-2.htm EX-10.2 4247
4 ex31-1.htm EX-31.1 35143
5 ex32-1.htm EX-32.1 7354
6 ex3-2_001.jpg GRAPHIC 144194
7 ex3-2_002.jpg GRAPHIC 100491
8 ex10-2_001.jpg GRAPHIC 156618
9 ex10-2_002.jpg GRAPHIC 211832
10 ex10-2_003.jpg GRAPHIC 112735
11 ex10-2_004.jpg GRAPHIC 33235
12 ex10-2_005.jpg GRAPHIC 52920
  Complete submission text file 0001493152-21-019946.txt   4807429

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE imun-20210630.xsd EX-101.SCH 39327
14 XBRL CALCULATION FILE imun-20210630_cal.xml EX-101.CAL 35431
15 XBRL DEFINITION FILE imun-20210630_def.xml EX-101.DEF 103484
16 XBRL LABEL FILE imun-20210630_lab.xml EX-101.LAB 261383
17 XBRL PRESENTATION FILE imun-20210630_pre.xml EX-101.PRE 188497
18 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 524497
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 211174849
SIC: 2834 Pharmaceutical Preparations